Veterinærmedicin: farmakologi

Plumb's(TM) VETERINARY DRUG HANDBOOKFind drug dosages and other critical information for prescribing drugs to animals quickly and efficiently in this fully updated new edition of this must-have veterinary resourceThe Tenth Edition of Plumb's(r) Veterinary Drug Handbook updates the most comprehensive, detailed, and trusted source of drug information relevant to veterinary medicine. Covering dosages, drug interactions, adverse effects, and contraindications, among other key drug details, this bestselling book is a must for practicing veterinarians and anyone requiring reliable information on the use of drugs in animals. Designed for ease of use, the book surveys an exhaustive list of drugs with applications for a wide variety of species, including dogs, cats, birds, small mammals, and farm animals.This edition includes updates to all 738 drug monographs and adds 30 new monographs, including 9 new insulin monographs, to its exhaustive coverage of drugs used in the care of animals. This new edition:* Provides an extensively reviewed and updated version of the must-have veterinary drug reference* Includes 30 new drug monographs, including 9 new insulin monographs* Updates all 738 drug monographs, with robust citing of new information* Covers a wide variety of species, including dogs, cats, birds, small mammals, and farm animals* Presents detailed dosing information for an exhaustive list of drugs used in animalsPlumb's(r) exhaustive coverage of drugs relevant to the veterinary field makes this book an essential reference for veterinarians, veterinary technicians, veterinary pharmacologists, pharmacists with veterinary patients, and libraries that serve these groups.

Diploma Thesis from the year 2017 in the subject Medicine - Pharmacology, grade: 4,0, University of Veterinary Medicine Budapest, course: Veterinary Medicine, language: English, abstract: This study is concerned with a comparison between the antibiotic agents marbofloxacin and gatifloxacin in fluoroquinolones and their efficiency in the treatment of Pseudomas aeruginosa.Pseudomonas aeruginosa, a major cause of extremely dangerous nosocomial infection, has become problematic in both human and veterinary medicine due to it¿s resistance to multiple drugs. Several experiments within research concerning development of bacterial resistance in P.aeruginosa have been reported. Imported resistance mechanism of P.aeruginosa is linked to mutations of DNA gyrase, the fluoroquinolone target, as well as overexpression of efflux pump. The worldwide, frequent use of different antibiotics contributes to a significant reduction in the bactericidal and bacteriostatic effect of different antibiotics. P.aeruginosa is represented as a ubiquitous organism present in environmental surroundings, and can be isolated from various living sources, including plants, animals, and humans. The ability of P. aeruginosa to survive on minimal nutritional requirements and to tolerate a variety of physical conditions has allowed this organism to persist in both community and hospital settings. Within hospitals, P. aeruginosa can be isolated from a variety of sources such as respiratory therapy equipment, antiseptics, soap, sinks, mops and medicines. As resistance to antibiotic is a relevant topic within today¿s global health care concerning both human and veterinary medicine, the curiosity for this expanding health problem resulted in a 9 days serial passage of P.aeruginosa in broth, investigating the susceptibility to marbofloxacin and gatifloxacin. The aim in this study was, therefore, to demonstrate that 4th generation fluoroquinolones appears to be more beneficial and efficient in the treatment of P.aeruginosa infections, than 2nd generation fluoroquinolones. In other words, the aim is to prove that gatifloxacin is of better use than marbofloxacin, due its antibiotic activity.